• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Economic Evaluation of the $35 Insulin Copay Cap Policy in Medicare and Its Implication for Future Interventions.

作者信息

Shao Hui, Guan Dawei, Fonseca Vivian, Shi Lizheng, Basu Anirban, Pop-Busui Rodica, Ali Mohammed K, Brown Joshua

机构信息

Center for Drug Evaluation and Safety, Department of Pharmaceutical Evaluation and Policy, University of Florida College of Pharmacy, Gainesville, FL.

Department of Medicine and Pharmacology, School of Medicine, Tulane University, New Orleans, LA.

出版信息

Diabetes Care. 2022 Nov 1;45(11):e161-e162. doi: 10.2337/dc22-1230.

DOI:10.2337/dc22-1230
PMID:36099174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9862367/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71cc/9862367/76a3458f74cf/dc221230f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71cc/9862367/76a3458f74cf/dc221230f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71cc/9862367/76a3458f74cf/dc221230f1.jpg

相似文献

1
Economic Evaluation of the $35 Insulin Copay Cap Policy in Medicare and Its Implication for Future Interventions.医疗保险中35美元胰岛素自付费用上限政策的经济评估及其对未来干预措施的启示。
Diabetes Care. 2022 Nov 1;45(11):e161-e162. doi: 10.2337/dc22-1230.
2
Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization.医疗保险D部分共付额政策变化对管理式医疗组织中医疗保险受益人的带状疱疹疫苗接种率的影响。
BMC Health Serv Res. 2017 Jul 21;17(1):503. doi: 10.1186/s12913-017-2441-7.
3
Estimates of Insulin Out-of-Pocket Cap-Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries.医疗保险受益人中与胰岛素自付费用上限相关的处方满意度、依从性和可负担性估计
JAMA Netw Open. 2023 Jan 3;6(1):e2251208. doi: 10.1001/jamanetworkopen.2022.51208.
4
Coverage of insulin delivery devices and basal insulin analogs by US managed care organizations.美国管理式医疗组织对胰岛素输注装置和基础胰岛素类似物的覆盖情况。
J Med Econ. 2011;14(6):720-8. doi: 10.3111/13696998.2011.613975. Epub 2011 Sep 8.
5
Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis.医疗保险D部分中患者自付费用与带状疱疹及破伤风-白喉-无细胞百日咳疫苗接种报销状态之间的关系。
Curr Med Res Opin. 2018 Jul;34(7):1261-1269. doi: 10.1080/03007995.2017.1416347. Epub 2018 Jan 10.
6
Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry.医疗保险 D 部分受益人达到灾难性限额后支付药品费用：政府与商业行业之间其他美国政策伙伴关系在费用分担方面的经验教训。
Appl Health Econ Health Policy. 2018 Dec;16(6):753-763. doi: 10.1007/s40258-018-0417-3.
7
Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.药物覆盖范围慷慨程度的变化与未经治疗的严重精神疾病：从医疗补助计划过渡到医疗保险部分 D。
JAMA Psychiatry. 2015 Feb;72(2):179-88. doi: 10.1001/jamapsychiatry.2014.1259.
8
The impact of Medicare prescription drug coverage on the use of antidementia drugs.医疗保险处方药覆盖范围对使用抗痴呆药物的影响。
BMC Geriatr. 2013 Apr 27;13:37. doi: 10.1186/1471-2318-13-37.
9
Medicare Part D research highlights and policy updates, 2013: impact and insights.2013 年医疗保险部分 D 研究重点和政策更新：影响与见解。
Clin Ther. 2013 Apr;35(4):402-12. doi: 10.1016/j.clinthera.2013.02.024. Epub 2013 Mar 29.
10
Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures.高 Medicare Part D 支出药物的成本效益研究的可用性。
JAMA Netw Open. 2021 Jun 1;4(6):e2113969. doi: 10.1001/jamanetworkopen.2021.13969.

引用本文的文献

1
Patient Out-of-Pocket Costs for Type 2 Diabetes Medications When Aging Into Medicare.当步入老年医保时，2 型糖尿病药物的患者自付费用。
JAMA Netw Open. 2024 Jul 1;7(7):e2420724. doi: 10.1001/jamanetworkopen.2024.20724.
2
The impact of a statewide insulin copay cap policy for insured patients with diabetes in Utah.犹他州针对参保糖尿病患者的全州胰岛素自付费用上限政策的影响。
J Manag Care Spec Pharm. 2024 Feb 3;30(2):112-117. doi: 10.18553/jmcp.2024.30.2.112.

本文引用的文献

1
Projected Impact of the Medicare Part D Senior Savings Model on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare.医疗保险处方药老年人储蓄模式对医疗保险覆盖的胰岛素使用者糖尿病相关健康和经济结果的预期影响。
Diabetes Care. 2022 Aug 1;45(8):1814-1821. doi: 10.2337/dc21-2601.
2
Trends in Total and Out-of-pocket Payments for Insulin Among Privately Insured U.S. Adults With Diabetes From 2005 to 2018.2005年至2018年美国患有糖尿病的私人保险成年人胰岛素总支付和自付费用趋势。
Diabetes Care. 2021 Aug 4. doi: 10.2337/dc20-2529.
3
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States.
美国成本效益分析的健康机会成本阈值。
Ann Intern Med. 2021 Jan;174(1):25-32. doi: 10.7326/M20-1392. Epub 2020 Nov 3.
4
Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary.利用议定价格和规定的处方集估算糖尿病患者的医疗保险处方药 D 部分胰岛素支出。
JAMA Intern Med. 2020 Apr 1;180(4):597-601. doi: 10.1001/jamainternmed.2019.7018.
5
Cost-Related Insulin Underuse Among Patients With Diabetes.糖尿病患者相关胰岛素使用不足的成本问题。
JAMA Intern Med. 2019 Jan 1;179(1):112-114. doi: 10.1001/jamainternmed.2018.5008.